SO-39 Evaluation of acquired resistance to sotorasib in KRAS p.G12C-mutated colorectal cancer: Exploratory plasma biomarker analysis of CodeBreaK 100
H. Prenen, M. Fakih, G. Falchook, J. Strickler, A. Hindoyan, A. Anderson, Arnold Ang, T. Kurata, T. Price
Topics & Concepts
KRASMedicineColorectal cancerInternal medicineOncologyClinical endpointCancerBiomarkerProgression-free survivalTumor progressionClinical trialOverall survivalGeneticsBiologyColorectal Cancer Treatments and StudiesChronic Lymphocytic Leukemia ResearchLung Cancer Treatments and Mutations